See also this year's filing and all EDGAR filings for this company.
PDF Report 0001208261_2013_Immune_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001208261, Immune Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,197,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 56,000 |
| 3 | remainder_Assets | 75,000 |
| 4 | LiabilitiesCurrent | 7,801,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 7,496,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,607,000 |
| 9 | ResearchAndDevelopmentExpense | 3,400,000 |
| 10 | remainder_Expenses | 403,000 |
| 11 | remainder_Revenues | 7,804,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -2,146,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,328,000 |
| 1 | Liabilities | 15,297,000 |
| 2 | Expenses | 8,410,000 |
| 3 | Revenues | 7,804,000 |
| 4 | StockholdersEquity | -13,969,000 |
| 5 | NetIncome | -606,000 |
| 6 | ComprehensiveNetIncome | -1,679,000 |
| 7 | BaseVar | 17,492,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.87 |
| 9 | EconomicCapitalRatio | 0.427 |
Edgar->Model Mapping
Feature Distribution
Change over Time
